Skip to main content
. 2018 Jun 26;2018:2798070. doi: 10.1155/2018/2798070

Figure 3.

Figure 3

ROS levels were tested using flow cytometry by the DCFH-DA fluorescent probe. There were significant differences between the Mfn2 overexpression group and the control group for ROS level of pancreatic cancer ( P < 0.05; N = 3).